per lonning

per lonning

University of Bergen, Norway
Email verificata su helse-bergen.no
Citato da 68725
Breast Cancer Endocrine therapy chemoresistance germline risk factors
Tian-Li Wang

Tian-Li Wang

Professor of Pathology, Oncology, and Gynecology/Obstetrics, Johns Hopkins University
Email verificata su jhmi.edu
Citato da 38010
Cancer genomics Epigenomics Notch signaling Chemoresistance
Sendurai A. Mani

Sendurai A. Mani

Associate Director for Translational Oncology, Legorreta Cancer Center at Brown University
Email verificata su brown.edu
Citato da 34192
cancer biology metastasis cancer stem cells EMT chemoresistance
Jose J. G. Marin

Jose JG Marin

University of Salamanca, Dept. Physiology and Pharmacology, HEVEPHARM, IBSAL …
Email verificata su usal.es
Citato da 19283
Hepatology Pathophysiology Pharmacology Chemoresistance
Anna-mart Engelbrecht

Anna-mart Engelbrecht

Stellenbosch University
Email verificata su sun.ac.za
Citato da 17361
breast cancer chemoresistance tumor microenvironment
Manfred Ogris

Manfred Ogris

Professor for Pharmaceutical Sciences, University of Vienna
Email verificata su univie.ac.at
Citato da 15557
Cancer gene therapy chemoresistance molecular imaging
Francisco Vega MD PhD

Francisco Vega MD PhD

MD Anderson Cancer Center
Email verificata su mdanderson.org
Citato da 11466
Hematopathology lymphoma chemoresistance Smoothened diffuse large B cell lymphoma
Rocio IR Macias

Rocio IR Macias

University of Salamanca
Email verificata su usal.es
Citato da 11122
Hepatology Chemoresistance Drug targeting Liver cancer
A. Emre Sayan

A. Emre Sayan

Assoc. Prof. in cancer cell biology, University of Southampton
Email verificata su soton.ac.uk
Citato da 9914
Cancer biology metastasis apoptosis chemoresistance epithelial mesenchymal transition
August Vidal i Bel

August Vidal i Bel

Hospital Universitari de Bellvitge-IDIBELL
Email verificata su bellvitgehospital.cat
Citato da 9701
Pathology gynecologic cancer chemoresistance animal models orthoxenografts
1 - 10